Trust Stamp announces allowance by the United States Patent and Trademark Office (“USPTO”) of a Non-Provisional Patent Application in respect of technology designed to identify deep fake and other Generative AI fuelled attacks in identity authentication processes 
Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture 
Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer Magellan Health Reports Second Quarter 2021 Financial Results
PHOENIX–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the second quarter ended…
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
Moderna COVID-19 Vaccine mRNA-1273: Final blinded analysis of Phase 3 COVE study shows 93% efficacy;…
ATX West and D&M West Reveal Highly Technical and Educational Conference Content Empowering Safe and Dynamic Global Factories
ANAHEIM, Calif.–(BUSINESS WIRE)–Informa Markets Engineering West, the nation’s leading advanced design and manufacturing event, which…
Trinity Fire & Security Systems Selects iland to Lead Cloud Transformation
UK fire and security systems company leaves traditional data centres behind, turning to iland Secure…
Infovista to showcase network lifecycle automation use cases at Big 5G Event 2021
Massy, France –– August 5, 2021. Infovista, the global leader in network lifecycle automation, today…
Artesian and DueDil Announce Strategic Partnership to Help FSI Companies Do Better Business, Faster
London, UK, 5th August 2021: Artesian Solutions today announced a new and exciting strategic partnership…
Athletico Physical Therapy Opens in Martinsville
MARTINSVILLE, Ind., Aug. 5, 2021 /PRNewswire/ — Athletico Physical Therapy has opened a new location…
Satori Announces Data Security Policy Engine to Streamline and Revolutionize Data Security for Large Enterprises
TEL AVIV, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) — Satori, the industry’s leading DataSecOps platform,…
Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy for Apathy in Alzheimer’s Disease
National Institutes of Health Funding to Support Ongoing Advancement of Innovative Treatments in Preventing and…
Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021
Company announcement – No. 49 / 2021 Zealand Pharma Hosts Conference Call on August 12 at…
Active Biotech AB Interim report January – June 2021
Good progress in the projects towards important clinical events SECOND QUARTER IN BRIEF Active Biotech…
Ultimovacs Announces First Patient Enrolled in Phase II FOCUS Trial of UV1 in Head-and-Neck Cancer
Study will assess the benefit of combining UV1 with standard of care pembrolizumab Topline data…
Ultimovacs announces first patient enrolled in Phase II FOCUS trial of UV1 in head-and-neck cancer
Study will assess the benefit of combining UV1 with standard of care pembrolizumab Topline data…
iOnctura Strengthens Management With Appointment of Sean A. MacDonald as Chief Business Officer
GENEVA, Switzerland, Aug. 05, 2021 (GLOBE NEWSWIRE) — iOnctura SA, a clinical stage oncology company…
Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update
ENHANCE Phase 3 program on track to report top-line data in 2022 Up to $219…
Noema Pharma Initiates Phase 2a Allevia Study of PDE10A Inhibitor NOE-105 in Tourette Syndrome
First Noema clinical trial, with asset in-licensed from Roche with strong clinical safety package Noema…
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
Pivotal study VLA1553-301 met its primary endpoint Vaccine candidate induced protective CHIKV neutralizing antibody titers…
Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update
Strong cash and cash equivalents position at June 30, 2021 of CHF18.1M ($19.6M) Pivotal dipraglurant…
ObsEva Announces Second Quarter 2021 Financial Results and Business Update
–Linzagolix (Yselty®) for uterine fibroids: US New Drug Application filing planned in Q3:21; European marketing…
Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus – Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors
Collaboration will initially explore the therapeutic potential of a combination of Imugene’s CF33-CD19 oncolytic virus…